APM
ORTX

Avidity Partners Management’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Avidity Partners Management’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-383,680
Closed -$8.82M – 116
2021
Q3 		$8.82M Buy
383,680
+5,500
+1% +$164K 0.2% 73
2021
Q2 		$16.6M Sell
378,180
-53,600
-12% -$2.99M 0.45% 56
2021
Q1 		$31.3M Buy
+431,780
New +$30.7M 0.87% 41

Other funds holding ORTX

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Avidity Partners Management's ORTX Position: Q4 2021 in Review

Avidity Partners Management sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q4 2021, closing a stake of 383,680 shares — an estimated $8.82M sold.

Avidity Partners Management first reported a position in ORTX in Q1 2021 and held it in 3 quarters. The position peaked at $31.3M in Q1 2021. 72 funds tracked by Wall St. Rank hold ORTX as of Q4 2021.

  • Avidity Partners Management reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q4 2021 after selling out during the quarter.
  • Avidity Partners Management sold 383,680 Orchard Therapeutics plc American Depositary Shares shares in Q4 2021, an estimated $8.82M.
  • Avidity Partners Management first reported a position in Orchard Therapeutics plc American Depositary Shares in Q1 2021 and held it in 3 quarters.
  • Avidity Partners Management's Orchard Therapeutics plc American Depositary Shares position peaked at $31.3M in Q1 2021.
  • 72 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q4 2021.

Based on Avidity Partners Management's 13F filing for Q4 2021, filed 14 Feb 2022.